|
|
|
|||
| Home Help Feedback Subscriptions Archive Search Table of Contents | ||||
First published online January 16, 2009
Journal of Experimental Biology 212, 413-423 (2009)
Published by The Company of Biologists 2009
doi: 10.1242/jeb.024216
Review |
Multipotent stem cells in the Malpighian tubules of adult Drosophila melanogaster
Mouse Cancer Genetics Program, National Institutes of Health, National Cancer Institute at Frederick, Frederick, MD 21702, USA
* Author for correspondence (e-mail: hous{at}mail.nih.gov)
Accepted 14 October 2008
| Summary |
|---|
|
|
|---|
Key words: kidney, Malpighian tubules, kidney development, multipotent stem cells, renal and nephric stem cells, renal cancer, Drosophila melanogaster
| Introduction |
|---|
|
|
|---|
The MTs of Drosophila melanogaster together with the hindgut, acts
as an excretory and osmoregulatory organ system. The MTs of the fly are
free-floating within the hemocoelic body cavity
(Dow et al., 1998
). MTs
perform several functions, including excreting metabolic waste, excess water
and organic metabolites (certain synthetic dyes); selectively reabsorbing the
fluid in the proximal tubules of MTs and hindgut; and acting as an autonomous
immune system (Maddrell et al.,
1974
; Denholm et al.,
2003
; Wang et al.,
2004
; Dow and Davies,
2006
; Jung et al.,
2005
; Ruiz-Sanchez and
O'Donnell, 2007
; Dow,
2007a
; Dow, 2007b
;
Evans et al., 2008
;
Day et al., 2008
). Mammalian
and fly kidney requires the proper integration and coordination in the
development of specialized cell types within a well-defined architectural
framework that functions in an integrated manner to maintain homeostasis of
body fluids, electrolytes and nutrients
(Jung et al., 2005
).
Common elements of renal development in mammals and Drosophila
The development of an organism requires proper integration and coordination
of cell behavior and cell–cell communication. Reciprocal inductive
interactions among cells result in cellular differentiation and formation of
tissues and organs. The kidney serves as an excellent model organ to
investigate the cellular and molecular mechanisms underlying organogenesis. It
is an important organ system in which to analyze most of the basic
developmental biology events, including epithelial–mesenchymal
interaction, branching morphogenesis, cell polarization and pattern formation
and differentiation (Vainio and Lin,
2002
; Jung et al.,
2005
; Dressler,
2006
).
The mammalian kidney develops from the intermediate mesoderm and proceeds
through three successive stages of development, each marked by the development
of a more advanced pair of organs: the pronephros, the mesonephros and the
metanephros. The adult metanephros develops by cycles of ureteric bud (UB)
branching and nephron formation. The cycles begin and are maintained by
reciprocal inductive interactions and by feedback between epithelial UB tips
and the surrounding metanephric mesenchyme (MM). In the process of these
interactions, branching of the UB is dependent on the MM, and the
differentiation of the nephrons is integrated with each new collecting tubule
(Saxen, 1987
;
Vainio and Lin, 2002
;
Dressler, 2006
). The
epithelial UB emanates from the Wolffian duct (WD), grows toward and invades
the adjacent MM, and then undergoes multiple interactions of a branching
program [mesenchymal-to-epithelial transition (MET)] that leads to the
development of an extensive urinary collecting system
(Dressler, 2006
;
Rosenblum, 2008
). MM cells
then condense around the tips of the growing and branching ureter and
aggregate at the tip of the UB to form an epithelial tubule that proceeds
through several morphological stages and ultimately gives rise to the nephron,
an excretory unit of the kidney (Fig.
1) (Saxen, 1987
;
Vainio and Lin, 2002
;
Wang et al., 2004
;
Jung et al., 2005
;
Dressler, 2006
;
Rosenblum, 2008
). The Bowman's
capsule, glomeruli, proximal and distal tubules arise from the MM and the
collecting ducts and the ureter arises from the UB
(Fig. 1). The continuous MET
generates
12,000 nephrons in the adult mouse kidney and
500,000 to
1,000,000 nephrons in the adult human kidney. Molecular genetic analyses of
the mammalian system have revealed a complex network of more than 400 genes
that control kidney organogenesis. These include the transcription factors,
signaling pathways, growth factors molecules, and transmembrane protein and
extracellular matrix molecules (Dressler,
2006
; Park et al.,
2007
; Yokoo et al.,
2008
; Uhlenhaut and Treier,
2008
). Elucidating the cells and the molecular basis of signaling
events involved during development will increase our understanding of the
molecular basis of hereditary and sporadic renal developmental defects, and
lead to useful new diagnostic and therapeutic tools that can be used to treat
kidney diseases and manipulate kidney function in adults.
|
Mammalian kidneys and Drosophila MTs show distinct similarities in
development and function. The development of both systems involves the
interaction of two distinct cell populations, one of which undergoes MET to
acquire key functional units. Even some of the pathways and molecules are
conserved in both systems during development
(Ainsworth et al., 2000
;
Denholm et al., 2003
;
Jung et al., 2005
). The
knowledge gained from the development and physiological function of
Drosophila MTs will provide a unique insight into the role of the
cellular pathways required in mammalian renal development and eventually lead
to a better understanding of complex renal diseases.
Stem cells in regeneration and repair of mammalian kidney
In recent years, stem cells have emerged as one of the fundamental
backbones of tissue biology. Stem cells are defined functionally as
unspecialized cells that have an unlimited capacity to self-renew through
mitotic cell division, as well as the ability to differentiate into a diverse
range of specialized cell types that support normal development and tissue
homeostasis. Both the self-renewal and differentiation processes must be
tightly regulated by two types of proliferative behavior, asymmetric and
symmetric division, to ensure the survival of an organism
(Yamanaka, 2007
;
Morrison and Spradling, 2008
;
Yamashita and Fuller, 2008
).
These unique properties of stem cells will provide a powerful tool for future
regenerative medicine and gene therapy. Growing evidence suggests that stem
cell self-renewal and differentiation is controlled by both intrinsic and
extrinsic factors, and that misregulation of stem cell behavior results in
cancer formation, tissue degeneration and premature aging.
In mammals, two kinds of stem cells, embryonic and adult, have been
identified, and each has distinct functions and characteristics. Embryonic
stem cells are considered as true stem cells, as they generate mature progeny
of all cell types; by contrast, the adult stem cells are thought to have
limited proliferation potential and can only differentiate into the mature
tissue in which they reside. However, the accumulative evidence suggests that
adult stem cells may have greater plasticity than previously recognized.
Despite their extensive proliferative capacities, stem cells may be quiescent
in vivo until injury or tissue degradation stimulates the
regenerative signal. The adult stem cells may repair the damaged tissues by
differentiating into appropriate cell phenotypes, by providing cytokines and
other factors to enhance recovery of endogenous cells, or by undergoing cell
fusion (Morris and Spradling, 2008). Adult stem cells play an important role
in cell turnover and regeneration. However, several obstacles exist in the use
of adult stem cells as disease therapy. First, the ability to identify most
adult stem cells is hampered by the lack of stem cell markers. Second, in
vitro systems for manipulating adult stem cell populations are often not
well defined. Finally, our understanding of how adult stem cells are regulated
within their niche is still far from complete. Multipotent adult stem cells
have been reported in many organs, such as bone marrow, skin, intestine,
prostate, pancreas, lung and testes, with unrestricted potential to form
different cell types after tissue injury
(Blanpain et al., 2007
;
Barker et al., 2008
).
Adult stem cells play an important role in cell turnover and regeneration.
The kidney, however, has a low rate of cellular turnover but has a great
potential for tissue regeneration following an ischemic or toxic injury.
Ischemic injury to the kidney causes acute renal failure, loss of tubular
polarity, necrosis and cell death, followed by tubular regeneration and
recovery of renal function (Anglani et al.,
2008
; Gupta and Rosenberg,
2008
; Yokoo et al.,
2008
; Vaidya et al.,
2008
). In humans, two broad categories of kidney disease have been
characterized: acute and chronic. Acute renal failure is a leading cause of
morbidity and mortality. Developmental studies reveal that the kidney has more
than 26 terminally differentiated cells types, suggesting that differentiation
potential would be helpful in renal regeneration after injury. Many animal
models provide evidence of regenerating completely degenerated renal tissues
after injury (Elger et al.,
2003
; Haller et al.,
2005
), which can help us understand the cellular and molecular
mechanisms of ischemic injury and tubular regeneration
(Imai et al., 2007
;
Gupta and Rosenberg, 2008
;
Yokoo et al., 2008
;
Vaidya et al., 2008
). There is
an ongoing debate about the source of proliferating cells (stem cells) in the
adult kidney that repopulate injured nephrons or regenerate the lost renal
tissues. Whether the adult stem cells that repopulate the renal tubule
following injury come from within the renal tubule or from extra-renal cells
remain controversial. Kidney regeneration and repair occur through three
possible sources of stem cells: dedifferentiation of surviving tubule cells,
bone marrow-derived stem cells or resident kidney stem cells
(Fig. 1)
(Oliver et al., 2004
;
Cantley, 2005
;
Duffield et al., 2005
;
Gupta et al., 2006
;
Imai et al., 2007
;
Imberti et al., 2007
;
Bussolati et al., 2008
;
Gupta and Rosenberg, 2008
;
Yokoo et al., 2008
;
Vaidya et al., 2008
). Stem
cell-based renal regeneration would be critical in reducing the incidence and
severity of acute renal failure and treatment of several other kidney diseases
and cancer.
Several studies in preclinical models of acute and chronic kidney injury
have demonstrated that cells from bone marrow (bone marrow-derived stem cells,
mesenchymal stem cells) may migrate to the kidney and participate in the
generation of new epithelial cells following injury (for details, see
Gupta and Rosenberg, 2008
;
Sagrinati et al., 2008
).
Mesenchymal stem cells have also been found to produce several growth factors
such as VEGF, HGF, IGF-1, BMP-7, and TGF-
, suggesting that, after renal
injury, a paracrine effect of renal vasculature may provide regeneration and
repair. Further studies have examined the role of bone marrow-derived stem
cells in renal regeneration, with different results
(Gupta and Rosenberg, 2008
;
Sagrinati et al., 2008
).
Moreover, several recent studies have shown that tubular cell replacement with
bone marrow-derived stem cells occurs less frequently than previously thought,
suggesting that these cells may not represent a major tool in cell therapy
after tubular injury and that regenerative cells originate from intra-renal
cells (Lin et al., 2005
). A
recent study even suggests that treatment of renal failure with bone marrow
stem cells can be offset by a partial maldifferentiation of bone marrow stem
cells into adipocytes, resulting in glomerular sclerosis
(Kunter et al., 2007
). Thus,
kidney-specific stem cells may be better for tissue replacement because of
their inherent organ-specific identity, which can reduce the risk of
maldifferentiation. Several other studies suggest that renal tubular injury
may be repaired by the less damaged cells, which can migrate, proliferate and
ultimately repopulate into normal renal tubules by the dedifferentiation
(Lin et al., 2005
;
Humpherys et al., 2008
).
Accumulative evidence suggests that the repair of kidney injuries is
predominately regulated by different endogenous renal stem cells
(Table 1). However, the
location and behavior of renal stem cells remain controversial. Adult kidney
stem cells have been isolated using four different selection strategies that
have been used to successfully isolate stem cells from other organs
(Gupta and Rosenberg, 2008
).
(1) BrdU (5-bromo-2-deoxyuridine) labeling. Because stem cells are
slow-cycling cells and they can retain the label for a long period of time and
it has been shown that label-retaining cells function as a source of
regenerating cells in adult kidney
(Maeshima et al., 2003
). These
cells remain, for a long period of time, at the interstitial cells of renal
papilla, and are multipotent in vitro
(Oliver et al., 2004
).
However, a recent study used the genetic fate mapping technique in mice to
exclude the presence of stem cells in the interstitial renal cells, and the
results indicate that surviving tubule epithelial cells are the predominant
mechanism of adult mammalian kidney repair after ischemic injury
(Humphreys et al., 2008
). (2)
Isolation of side-population (SP) cells because these cells extrude Hoechst
dye through the activity of multidrug resistance proteins of the ATP-binding
cassette transporter superfamily (Gupta
and Rosenberg, 2008
). SP cells (Hoechst low cells) isolated from
many different organs are multipotent stem cells
(Challen and Little, 2006
)
Stem cells are also found in the SP cells of the adult kidney with
multilineage differential potential
(Iwatani et al., 2004
;
Challen et al., 2006
). (3) The
identification and isolation of kidney stem cells using specific cell surface
markers that have been used to identify stem cells in other organs including
kidney. Gupta et al. (Gupta et al.,
2006
) identified multipotent renal stem cells in the proximal
tubules of the rat kidney and showed that these cells express several markers,
including CD90, Oct4 and Pax2. Recently, multipotent renal stem cells have
been identified in the adult human kidney in a subset of parietal epithelial
cells located in Bowman's capsule
(Bussolati et al., 2005
;
Sagrinati et al., 2006
). These
progenitor cells have the ability to self-renew and differentiate into several
cell types in the kidney, and are characterized by the expression of stem cell
markers, such as CD24, CD133, SDF1, CXCR4 and CXCR7
(Sagrinati et al., 2006
;
Mazzinghi et al., 2008
). These
findings in the adult human kidney suggest that CD24, CD133, SDF1, CXCR4 and
CXCR7 play an essential role in the therapeutic homing of human renal
progenitor cells in acute renal failure, with important implications for the
development of stem cell-based therapies for renal injury
(Mazzinghi et al., 2008
). (4)
Using specific culture conditions that have been used widely in selecting stem
cells in other organ systems it has been shown that multipotent renal
progenitor cells isolated from kidney express the stem cell markers and can
differentiate into mature tubular cells
(Kitamura et al., 2005
;
Gupta et al. 2006
).
|
The characterization of stem cells in other adult organs, together with
evidence from animal and human models for renal tubule repair or regeneration
after injury, strongly suggests the presence of adult renal stem cells.
However, the precise source and location of renal stem cells in the adult
kidney remain unclear. Subsequently, the stem cells markers in the adult
kidney are also lacking or less well characterized, making it difficult to
isolate, to define a renal stem cell niche, or to follow cell lineage
progression in the normal or injured kidney
(Gupta and Rosenberg, 2008
). A
summary of the isolation and localization of kidney stem cells, including
candidate markers, in different species is presented in
Table 1. However, precise
identification and characterization of adult kidney stem cells and signaling
pathways regulating their self-renewal or differentiation are poorly
understood. Additionally, clonal analysis might be essential for comparing the
different mechanisms underlying renal repairs. Understanding the signaling
pathways regulating the proliferation and differentiation of adult kidney stem
cells will undoubtedly provide the development of novel therapeutic strategies
for the treatment of acute kidney injury
(Humphreys et al., 2008
).
Stem cells in the renal tubules of adult Drosophila
The development of Drosophila MTs is completed during
embryogenesis. The MTs remain intact during metamorphosis but undergo some
structural changes. Tissue homeostasis is critical for the maintenance of
adult tissues. Most, if not all, adult epithelia of mammals and MTs have a
well-defined organizational structure. Epithelial tissue can be classified
into two broad categories based on turnover time: rapidly self-renewing and
persistent. Most of the mammalian adult epithelial tissues, such as intestine,
skin, cornea and mammary gland, undergo rapid self-renewal and replace damaged
or dead cells throughout the life of the animal. Studies on epithelial tissue
turnover suggest that cell self-renewal varies among different types of
epithelial tissues. Drosophila is a highly attractive model system
for the study of several important, complex biological processes, including
epithelial tissue turnover.
Historically, the adult organs of Drosophila have been viewed as
strictly postmitotic. Detailed studies exist on the adult stem cells of the
reproductive system of Drosophila (see
Hou and Singh, 2008
). However,
the existence of multipotent cells in adult Drosophila epithelial
tissues did not become clear until recently
(Micchelli and Perrimon, 2006
;
Ohlstein and Spradling, 2006
;
Ohlstein and Spradling, 2007
;
Singh et al., 2007
;
Takashima et al., 2008
).
Recent studies have shown that the Drosophila midgut contains many
multipotent stem cells that lie close to the extracellular matrix, and Notch
signaling regulates self-renewal or differentiation of these stem cells
(Micchelli and Perrimon, 2006
;
Ohlstein and Spradling, 2006
;
Ohlstein and Spradling, 2007
).
Additionally, there is an age-related increase in the number and activity of
midgut stem cells and progenitor cells, regulated by PDGF and/or VEGF
(Choi et al., 2008
). Another
study has identified adult stem cells in hindgut of Drosophila that
are regulated by Wingless (Wnt), Hedgehog (Hh) signaling
(Takashima et al., 2008
).
During metamorphosis, the larval gut degenerates, the gut is entirely
remodeled, and the adult gut is formed. However, the Malpighian tubules are
not remodeled during metamorphosis and remain almost unmodified in the adult.
How cell turnover is managed in the adult MT cells and what factor(s)
regulates MT cell self-renewal were unknown until we identified the cells with
small nuclei in the region of the lower tubules and ureters of the MTs in
adult Drosophila. These stem cells function as multipotent stem
cells, capable of differentiating into all cell types in the tubule and
regulated by an autocrine JAK-STAT signaling
(Fig. 2A–H)
(Singh et al., 2007
;
Singh and Hou, 2008
). The
details of the identification and characterization of the behavior of stem
cells in the renal tubules of the adult Drosophila are described
below.
|
80%) of the cells found in
the initial, transitional and main segments, and the region of lower tubules
and ureters; Type I cells transport cations and organic solutes. Type II cells
that express Teashirt (Tsh), conduct water and chloride ions, and are found in
the initial, transitional and main segments, but not in the region of lower
tubules and ureters (Wessing and
Eichelberg, 1978
We also asked whether cells in the MTs are proliferating and mitotically active throughout adult life. The epithelial cells can be labeled by continuous incorporation of the nucleotide analog BrdU for a long period of time; during the chase period, the label in the cells is diluted through cell division. The more slowly dividing cells, however, can retain the labeling for a longer period, and cell division can be observed in postmitotic tissues. We found that when BrdU (a proliferating marker) is incorporated, it labels all three cell types in the lower tubules and ureters. However, no BrdU-labeled cells have been seen in the upper tubules. Since many cells undergo endoreplication in both larvae and adult tissues, the BrdU can label both endoreplicating and dividing cells. To distinguish endoreplicating cells from dividing cells in the MTs, we stained the tissue for phosphorylated-histone-H3 (H3P), which plays an important role in gene expression, chromatin remodeling, chromosome condensation and cell division. H3P may initiate at different phases of the cell division in different organisms, but metaphase chromosomes are always found to be heavily phosphorylated. H3P is used as a mitotic marker in a wide range of organisms. In contrast to BrdU labeling, which occurs in all three cell types in the lower tubules and ureters, we detected H3P staining in cells with small nuclei, suggesting that the cells with small nuclei divide and the cells with intermediate and large nuclei undergo endoreplication. Additionally, we characterized several cell-specific molecular markers, such as two transcription factors, Escargot (Esg), and Kr and a membrane protein (Fig. 2B), Armadillo (Arm; the β-catenin homolog), which is expressed in small-nuclear-sized cells in the lower tubules and ureters. Furthermore, we found that both Esg and Kr sometimes present in a pair of H3P-positive dividing cells. Since the function of the esg gene is to maintain cells as diploid in Drosophila imaginal cells, the Esg-positive cells in the MTs are most probably diploid cells.
Cells with small nuclei in the proximal tubules of MTs are multipotent stem cells
To determine whether stem cells maintain cell turnover in the MTs, and if
so, whether stem cells are able to recruit different types of cells to the
tubule, we used a positively marked mosaic lineage (PMML) labeling technique
(Kirilly et al., 2005
) to
label and trace cells that undergo mitotic divisions. Genetic lineage labeling
in Drosophila involves using heat shock to induce a mitotic genetic
recombination event that results in permanent expression of an easily
visualized reporter transgenes [such as GFP (green fluorescent protein) or
lacZ (β-galactosidase)] in a proliferating cell as well as in
all progeny of that cell. Because the recombination event is infrequent, only
single cells in a small area are labeled, and upon proliferation of these
cells over time, the labeled cells make a small cluster. We heat-shocked the
flies and observed the fate of the GFP-marked clones in adult MTs from
2–10 days after clone induction. By 2 days after clone induction, GFP
had labeled a few cells with small nuclei in the basal region of the ureter
and lower tubules, and we observed a few transient clones of cells with large
nuclei and limited proliferation potential. By 4–6 days after clone
induction, clones were restricted mainly to the region of the lower tubules
and ureter, with individual cells with small nuclei and clusters of cells with
small, intermediate and large nuclei. We found that most basal diploid cells
with small nuclei function as stem cells, and we term these the renal and
nephric stem cells (RNSCs). The RNSCs contacted their immature diploid
daughters, which we term the renalblasts (RBs), and these RBs underwent two
fates: in the lower tubules and ureters, the RBs began to increase in size and
DNA content, to become cells with intermediate and large nuclei in
5
days, and express Cut. We term the intermediate and large nucleus cells early
and late renalcytes (RCs), respectively
(Fig. 2E–F,H). Ten days
following clone induction, the RBs moved toward the distal upper tubules and
finally differentiated into Cut-positive PCs and Tsh-positive SCs in the
transitional and initial segments (Fig.
2G,H). Using different molecular markers and clonal analysis, we
also found that, out of
500 cells in one pair of anterior MTs, >90
cells were RNSCs. This analysis suggests that cells with small nuclei in the
regions of the lower tubules and ureters function as multipotent stem cells in
the renal tubules because they are able to proliferate and differentiate into
several types of cells (Fig.
2E–H).
Regulation of stem cell behavior in MTs
Understanding what regulates stem cell behavior will allow to us to predict
behavior during development and homeostasis, and after disease. Additionally,
determining how signaling pathways or molecules regulate stem cell
self-renewal and differentiation is a critical step toward manipulating adult
stem cells for therapeutic purposes. The various stem cell niches found in
organisms from insects to mammals appear to have common signal transduction
pathways, including the JAK-STAT, canonical Wnt, Hh and Notch pathways
(Li and Xie, 2005
;
Ohlstein and Spradling, 2007
;
Hou and Singh, 2008
;
Morrison and Spradling, 2008
;
Takashima et al., 2008
;
Nusse, 2008
). The existence of
a stem cell niche has been proposed for several adult stem cell systems
(Martinez-Agosto et al., 2007
;
Jones and Wagers, 2008
). The
precise spatial organization of the stem cells and the surrounding supporting
cells is important to provide the proliferative signal and to avoid factors
that enhance differentiation. Maintaining the balance between
proliferation-inhibiting and proliferation-stimulating signals is the key to
maintaining tissue homeostasis. Adhesion between stem cells and support cells
plays an important role in keeping stem cells within the niche so that they
may receive the self-renewal signal. Additionally, the niche may provide the
polarity signal, which orients stem cells within the niche
(Yamashita and Fuller, 2008
).
Stem cells niches are well characterized in the adult testis and ovary of
Drosophila, where a fixed niche regulates stem cell self-renewal
(Kiger et al., 2001
;
Lin, 2002
;
Brawley and Matunis, 2004
;
Li and Xie, 2005
;
Decotto and Spradling, 2005
;
Wang et al., 2006
;
Nystul and Spradling, 2007
;
Hou and Singh, 2008
;
Voog et al., 2008
). However,
in the MTs, the renal stem cells do not adhere to a particular cell type and
are scattered over the region of the proximal tubules. If there is no fixed
niche for renal stem cells in MTs, what factor(s) regulate their self-renewal
and differentiation? To determine what signaling or molecules regulate renal
stem cells behavior in MTs, we examined the expression pattern of the JAK-STAT
pathway components because the signaling regulates stem cell self-renewal in
several other stem cell systems. The Drosophila JAK-STAT pathway
components are illustrated in Fig.
3. These components are: JAK, encoded by the hop
(hopscotch) gene; STAT, encoded by the Stat92E
(signal-transducer and activator of: transcription protein at 92E) gene; a
ligand, encoded by the upd (unpaired) gene; a receptor,
encoded by the dome [domeless; also known as mom
(Master of Marrelle)] gene; and several negative regulators such as
suppressor of cytokine signaling at 36E (Socs36E), ken
and barbie (ken), protein inhibitors of activated stats
(PIAS), and nucleosome remodeling factor (NURF)
(Luo and Dearolf, 2001
;
Hou et al., 2002
;
Agaisse and Perrimon, 2004
;
Singh et al., 2005
;
Hombría and Sotillos,
2006
; Arbouzova and Zeidler,
2006
; Gregory et al.,
2008
). The activated Stat92E enters the nucleus to activate the
transcription of its target genes (Fig.
3). We observed that most of the components of JAK-STAT signaling
in MTs is expressed in cells with small nuclei of the lower tubules and ureter
region (Fig. 2C,D). They are
also sometimes positive for H3P, suggesting that these cells are mitotically
active and are expressed in renal stem cell or their immediate daughter
RBs.
|
We also examined the role of JAK-STAT signaling in renal stem cells by
using the PMML technique. We found that when we overexpressed the JAK-STAT
ligand Upd, the size of the MT increased. We also saw a dramatic increase in
the expression of Stat92E, as well as in the number of proliferating cells,
mitotically active cells, and renal stem cells, compared with wild-type MTs.
These observations suggest that overexpression of Upd makes renal stem cells
more active and accelerates cell division of the RNSCs. When we reduced the
JAK-STAT signaling by using the PMML technique to overexpress
Socs36E, the renal stem cells differentiated prematurely.
Furthermore, we determined whether JAK-STAT signaling was directly required in
renal stem cells. Using the mosaic analysis with the repressible cell marker
(MARCM) technique (Lee and Luo,
2001
), we analyzed Stat92E homozygous clones in the MTs and found
that the absence of JAK-STAT signaling promotes the differentiation of RNSCs,
as well as the loss of stem cell population. Furthermore, using Apoptag
staining we found that the loss of RNSCs is not due to cell death. Next, we
observed the expression pattern of the JAK-STAT ligand Upd and its receptor
Dome in the MTs and found that both the ligand and its receptor, along with
Stat92E protein, are expressed in RNSCs. Using these findings, we proposed
that self-renewal of RNSCs is controlled by autocrine JAK-STAT signaling and
does not need a fixed niche. This is similar to intestinal stem cells (ISCs)
in adult Drosophila midgut, where ISCs do not rely on any fixed
anatomic niche because ISCs themselves play an active role in supplying
signals, such as the Delta ligand, to their daughters to control their
proliferation and differentiation
(Ohlstein and Spradling, 2006
;
Ohlstein and Spradling, 2007
).
However, the RNSCs reside primarily in the lower tubules and ureters, even in
Upd-overexpressing flies, suggesting that, in addition to JAK-STAT signaling,
other signaling or molecules restrict the RNSCs to the lower tubules and
ureters. Furthermore, in observing the activity of JAK-STAT signaling in MTs
by using a Stat92E-GFP reporter, which is expressed in cells with small nuclei
between the ureter and the lower part of the main segment, we noticed that
some cells with small nuclei strongly express GFP, and others weakly express
GFP. These observations suggest that high JAK-STAT signaling regulates RNSC
self-renewal, whereas weak JAK-STAT signaling prepares an RB for
differentiation into an RC in the lower tubules and ureters, and into a PC or
SC in the upper tubules (Fig.
2H). These findings on the MTs of adult Drosophila
suggest that resident stem cells may be involved in repair and/or regeneration
of the renal tissues after acute and/or ischemic injury in the mammalian
kidney, and that a fixed niche may not be needed to maintain the self-renewal
of renal stem cells (Singh et al.,
2007
; Affolter and Barde,
2007
; Singh and Hou,
2008
).
Stem cells and kidney cancer
The normal development of the mammalian kidney begins with a reciprocal
inductive interaction between the UB and MM that leads to the evolution of the
collecting duct system and nephrons, respectively. This process requires a
proper sequence and balance of proliferation, cell–cell interactions,
apoptosis and differentiation. Any misregulation in these processes may lead
to kidney disease, including acute or chronic renal failure, polycystic kidney
disease or glomerulonephritis or kidney cancer. Globally, more than 500
million individuals have some form of chronic kidney disease (CKD). Most of
these individuals depend on dialysis and rarely receive transplants because of
the limited availability of the organ.
Cancer is a leading cause of death worldwide. Cancer begins when a group of
cells display uncontrolled growth, invasion and sometimes metastasis. The
malignant tumors develop through the accumulation of genetic changes in
proliferating cells, such as the activation of oncogenes, dysfunction of
stability genes, or inactivation of tumor-suppressor genes. Kidney cancer is a
combination of different types of cancer, each with a different histology,
requiring different clinical courses and responding to different forms of
therapy, and each associated with the alteration of a different gene. Renal
cell carcinoma (RCC) is the most common type of kidney cancer, accounting for
more than 90% of malignant kidney tumors. RCC originates primarily in proximal
renal tubules and, rarely, in collecting ducts
(Fig. 4). Like most cancers,
RCC is difficult to treat once it has metastasized. The five human genes
associated with predisposition to RCC are: von Hippel-Lindau (VHL;
clear cell RCC); met proto-oncogene (MET; papillary RCC); fumarate
hydratase (FH; papillary RCC); Birt-Hogg-Dubé [BHD
(also known as FLCN); chromophore oncocytomas, clear cell]; and
hyperparathyroidism 2 [HRPT2 (also known as CDC73);
papillary RCC; Fig. 4]. RCC
could develop following chronic renal regeneration and repair in individuals
with polycystic kidney disease or in renal allograft. A detailed investigation
of kidney neoplasms suggests that some RCCs, such as Wilms' tumor (WT) and
hereditary papillary renal carcinoma, are caused by mutations in the genes
involved in normal nephrogenesis. WT is a pediatric kidney cancer that arises
from multipotent embryonic renal precursors of the metanephric blastema that
fail to differentiate. Some of the neoplasms are caused by mutations in genes
expressed during normal development; for example, RCC is associated with the
tuberous sclerosis complex (TSC) gene, and clear cell renal carcinoma with the
VHL gene. The majority of RCCs develop in abnormalities of renal epithelial
cells, and only a mutation in TSC causes abnormalities in both
mesenchymal cells and epithelial cells
(Fig. 4)
(Henske, 2005
;
Pfaffenroth and Linehan,
2008
).
|
Studies of the genetic conditions associated with RCC, such as VHL, BHD and
MET, as well as genetic analyses of the tumors have provided considerable
insight into the pathogenesis of these lesions. Although RCC is resistant to
chemotherapy, kinase inhibitors and interleukin-2 are used to treat advanced
RCC. However, because of the side effects, these therapies are not effective.
Cancer is considered a stem-cell disease because of both its propagation by a
minority of cells with stem-cell-like properties (termed cancer stem cells, or
CSCs) and its possible derivation from normal-tissue stem cells (Sneddon and
Werb, 2008). Furthermore, overlapping sets of molecules and pathways regulate
both stem cell migration and cancer metastasis. Normally, most adult stem
cells reside in a quiescent state. However, the effect of repeated injury (as
in chronic kidney injury, for example) would, over time, increase the pool
size of stem cells in an active state of renewal and increase cancer
incidence. The presence of more stem cells in a tissue may enhance the
possibility of a stem cell being trapped in the activated state by an
oncogenic event (Beachy et al.,
2004
).
Abnormal functioning of signaling pathways is believed to contribute to the
pathogenesis of many malignancies and is particularly relevant to renal
cancers. To understand the cancer stem cells in tumors, we need to know first
what signaling pathways and pathway interactions regulate cancer formation. It
has been shown that the TSC complex [TSC1–TSC2 (also known as hamartin
and tuberin)] regulates early renal progenitor cells because individuals with
TSC mutations have an increased incidence of RCC. Mutations in the TSC
activate the mammalian target of rapamycin (TOR) by inhibiting RHEB (RAS
homolog enriched in brain) and the biochemical phenotypes resemble those of
VHL. In addition, TOR has been shown to regulate hypoxia inducible factor
(HIF) activity, and much evidence implicates TOR as a valid target for
treatment of renal cell carcinoma. Epidermal growth factor receptor (EGFR)
activates phosphoinositide 3-kinase and downstream targets including AKT
(protein kinase B) and TOR, resulting in increased HIF-1 expression leading to
tumor metastasis. The MET proto-oncogene, expressed in both stem and cancer
cells, is a key regulator of invasive growth in normal conditions because it
binds with HGF to induce receptor dimerization and phosphorylation, and
interacts with several other intracellular factors, including the RAS
oncogene–mitogen-activated protein kinase (RAS-MAPK) and protein kinase
B (AKT) pathways. VHL, a tumor-suppressor gene, plays a role in the
regulation of tumor angiogenesis by targeting the hypoxia-inducible growth
factor 1 (HIF1) for ubiquitin-mediated degradation. HIF1 induces the
dedifferentiation of cancer cells, maintains stem cell identity, and increases
the metastatic potential (Kondo et al.,
2003
). VHL interacts with HIF1, resulting in the loss of VHL and
overproduction of the HIF1, which contributes to the development RCC. These
observations suggested that the HIF is the potential therapeutic target of
VHL. Furthermore, genetic inactivation of VHL prevents HIF1 down-regulation,
leading to the expression of the MET proto-oncogene, an important regulator of
invasion and metastasis. VHL and glycogen synthase kinase 3 (GSK3) function
together in a ciliary-maintenance signaling network, disruption of which
enhances the vulnerability of cells to lose their cilia, thereby promoting
cyst formation. Recently it has been reported that PTEN (phosphatase and
tensin homolog) tumor-suppressor protein cooperates with VHL to regulate
kidney tumorigenesis (Frew et al.,
2008
). STRA13 is a cancer-associated protein regulated by VHL and
the HIF1 pathway, and is overexpressed in many common malignancies. VHL
deficiency or HIF1 activation results in the repression of endogenous STAT1,
which possesses tumor-suppressor properties and is mediated by STRA13
(Ivanov et al., 2007
). BHD is
another dominantly inherited hamartoma syndrome
(Schmidt et al., 2005
) that
shares several features with TSC; mutation in both genes causes renal
carcinoma, which suggests that the BHD and TSC proteins may function within a
common pathway. However, clinical phenotypes and the risk of malignancy are
higher in BHD than in TSC. Recently, we demonstrated that amplifying the
JAK-STAT signaling by overexpressing its ligand Upd stimulates the RNSCs to
proliferate and differentiate into RCs, which results in tumorous overgrowth
in the MT (Singh et al.,
2007
). Previously, we have reported that BHD interacts with
JAK-STAT signaling and regulates germline stem cell in the Drosophila
testis and functions downstream of JAK-STAT signaling pathways
(Singh et al., 2006
).
Therefore, the Drosophila RNSC system may also be a valuable in
vivo system in which to study cancer stem cell regulation in renal
tubules. The genetic interactions of different oncogenes and tumor-suppressor
genes regulating renal carcinoma and other kidney cancers are summarized in
Fig. 5. A key goal in clinical
oncology is the development of medical therapies specific to pathways that are
misregulated in cancer. Understanding the biological pathways involving
VHL, MET, FH, BHD and HRPT2 will provide new therapeutic
approaches for kidney cancer.
|
The incidence of end-stage renal disease in patients with chronic kidney
disease is predicted to rise in the near future, and probably will not be
counterbalanced by currently available renal replacement therapies such as
hemodialysis and hemofiltration (Braam et
al., 2007
). These therapies repair or replace only the filtration
function for small solutes and do not replace the lost transport, metabolic
and endocrine functions of the kidney. In addition to conventional methods of
renal therapy, four innovative ways have been suggested to restore the normal
function of the kidney cells after chronic disease or ischemic injury. First,
damaged kidneys can be restored by stem cell technology (cell-targeted
therapy) and knowledge of developmental programming; second, using therapeutic
cloning, a kidney may be grown in vitro and transplanted into the
recipient; third, other organs may be used to replace various renal functions;
and finally, the artificial kidney may be used, which has the potential to be
supplemented with human cells (Challen et
al., 2006
; Braam et al.,
2007
). These innovative therapies to replace the functions of the
kidney, particularly stem cell therapy, may provide invaluable treatments for
renal failure. Furthermore, understanding the response to tissue injury, as
well as the signals that regulate the activation of tissue stem cells, will
provide potential strategies for the use of stem cells in cancer prevention
and therapy.
Conclusions and future prospects
Regardless of several differences, the general organization and physiology
of mammalian kidneys and Drosophila MTs show clear similarities in
development and function. Both use common strategies of development, and even
some of the pathways and molecules are conserved in both systems. Adult stem
cells have been well defined to contribute to tissue regeneration after injury
in various organ systems. The recruitment of stem cells to the injured tissue
therefore appears to be the prerequisite for repair, and understanding the
mechanisms that regulate their migration is crucial for the success of any
clinical strategy involving stem cells. Despite the abundant promise of
progress, there remains the essential challenge in understanding the role of
stem cells in the kidney. Therefore, identifying and characterizing this role
is critical to renal research, which must move forward before approaches to
therapy and repair, can be fully realized.
Using genetic-labeling techniques and molecular markers, we have identified many multipotent stem cells in the MTs of the adult Drosophila. These renal stem cells have the ability to generate all cell types of the adult. Furthermore, we found that autocrine JAK-STAT signaling regulates self-renewal or differentiation of renal stem cells. However, several important questions remain regarding the biological properties of multipotent stem cells in Drosophila renal tubules, such as how the self-renewal or differentiation is balanced in the MTs to avoid tissue overgrowth; whether their self-renewal is unlimited; what are the molecular mechanisms controlling asymmetric stem cell division; whether cell polarity, centrosomal asymmetry, and cell cycle regulators, determines asymmetric division of RNSCs, as in other stem cell systems; and finally, how the tumor suppressor genes regulate stem cell proliferation and self-renewal in MTs. Answering these questions is crucial and will provide a better understanding of the mechanisms behind self-renewal, proliferation and differentiation of stem cells in general.
Studies to determine the sources of kidney regeneration after injury and
the existence of stem cells and their location have produced conflicting
results in the mammalian system, and several experiments are needed to
identify the sources and types of cells involved in this process. Furthermore,
strategies must be developed to overcome the severity of tubular injury and
find a better way to improve the capability of tubular regeneration after
acute renal failure. Identification of multipotent stem cells in adult
Drosophila MTs suggests that resident stem cells may be responsible
for repair and regeneration of completely damaged tissues in the mammalian
kidney (Humphreys et al.,
2008
). Understanding the function of multipotent kidney stem cell
in adults, combined with powerful, state-of-the-art forward- and
reverse-genetic approaches, genomics, and proteomics tools, and studies of the
Drosophila renal stem cell system, will lead to a better
understanding of kidney development. Understanding this process has important
clinical implications for early detection, prevention and treatment of several
kidney diseases, including cancer.
List of abbreviations
| Footnotes |
|---|
| References |
|---|
|
|
|---|
Affolter, M. and Barde, Y. (2007). Self-renewal in the fly kidney. Dev. Cell 13,321 -322.[CrossRef][Medline]
Agaisse, H. and Perrimon, N. (2004).The roles of JAK/STAT signaling in Drosophila immune responses. Immunol. Rev. 198,72 -82.[CrossRef][Medline]
Ainsworth, C., Wan, S. and Skaer, H. (2000).
Coordinating cell fate and morphogenesis in Drosophila renal tubules.
Philos. Trans. R. Soc. Lond., B, Biol. Sci.
355,931
-937.
Anglani, F., Ceol, M., Mezzabotta, F., Torregrossa, R., Tiralongo, E., Tosetto, E., Del Prete, D. and D'Angelo, A. (2008). The renal stem cell system in kidney repair and regeneration. Front. Biosci. 13,6395 -6405.[Medline]
Arbouzova, N. I. and Zeidler, M. P. (2006). JAK/STAT signaling in Drosophila: insights into conserved regulatory and cellular functions. Development 133,1605 -1616.
Barker, N., van de Wetering, M. and Clevers, H.
(2008). The intestinal stem cell. Genes
Dev. 22,1856
-1864.
Beachy, P. A., Karhadkar, S. S. and Berman, D. M. (2004). Tissue repair and stem cell renewal in carcinogenesis. Nature 432,324 -331.[CrossRef][Medline]
Blanpain, C., Horsley, V. and Fuchs, E. (2007). Epithelial stem cells: turning over new leaves. Cell 128,445 -458.[CrossRef][Medline]
Braam, B., Verhaar, M., Blankestijn, P., Boer, W. H. and Joles, J. A. (2007). Technology insight: innovative options for end-stage renal disease – from kidney refurbishment to artificial kidney Nat. Clin. Pract. Nephrol. 3, 564-572.[CrossRef][Medline]
Brawley, C. and Matunis, E. (2004).
Regeneration of male germline stem cells by spermatogonial dedifferentiation
in vivo. Science 304,1331
-1334.
Bussolati, B., Bruno, S., Grange, C., Buttiglieri, S.,
Deregibus, M. C., Cantino, D. and Camussi, G. (2005).
Isolation of renal progenitor cells from adult human kidney. Am. J.
Pathol. 166,545
-555.
Bussolati, B., Tetta, C. and Camussi, G. (2008). Contribution of stem cells to kidney repair. Am. J. Nephrol. 28,813 -822.[CrossRef][Medline]
Cantley, L. G. (2005). Adult stem cells in the repair of the injured renal tubule. Nat. Clin. Pract. Nephrol. 1,22 -32.[CrossRef][Medline]
Challen, G. A., and Little, M. H. (2006). A side order of stem cells: the SP phenotype. Stem Cells 24, 3-12.[CrossRef][Medline]
Challen, G. A., Bertoncello, I., Deane, J. A., Ricardo, S. D.
and Little, M. H. (2006). Kidney side population reveals
multilineage potential and renal functional capacity but also cellular
heterogeneity. J. Am. Soc. Nephrol.
17,1896
-1912.
Chintapalli, V. R., Wang, J. and Dow, J. A. (2007). Using fly atlas to identify better Drosophila melanogaster models of human disease. Nat. Genet. 39,715 -720.[CrossRef][Medline]
Choi, N. H., Kim, J. G., Yang, D. J., Kim, Y. S. and Yoo, M. A. (2008). Age-related changes in Drosophila midgut are associated with PVF2, a PDGF/VEGF-like growth factor. Aging Cell 7,318 -334.[CrossRef][Medline]
Curtis, L. M., Chen, S., Chen, B., Agarwal, A., Klug, C. A. and
Sanders, P. W. (2008). Contribution of intrarenal cells to
cellular repair after acute kidney injury: subcapsular implantation technique.
Am. J. Physiol. Renal Physiol.
295,F310
-F314.
da Silva Meirelles, L., Chagastelles, P. C. and Nardi, N. B.
(2006). Mesenchymal stem cells reside in virtually all post-natal
organs and tissues. J. Cell Sci.
119,2204
-2213.
Day, J. P., Wan, S., Allan, A. K., Kean, L., Davies, S. A.,
Gray, J. V. and Dow J. A. (2008). Identification of two
partners from the bacterial Kef exchanger family for the apical plasma
membrane V-ATPase of Metazoa. J. Cell Sci.
121,2612
-2619.
Decotto, E. and Spradling, A. C. (2005). The Drosophila ovarian and testis stem cell niches: similar somatic stem cells and signals. Dev Cell. 9, 501-510.[CrossRef][Medline]
Dekel, B., Zangi, L., Shezen, E., Reich-Zeliger, S.,
Eventov-Friedman, S., Katchman, H., Jacob-Hirsch, J., Amariglio, N., Rechavi,
G., Margalit, R. et al. (2006). Isolation and
characterization of nontubular sca-1+lin-multipotent stem/progenitor cells
from adult mouse kidney. J. Am. Soc. Nephrol.
17,3300
-3314.
Denholm, B., Sudarsan, V., Pasalodos-Sanchez, S., Artero, R., Lawrence, P., Maddrell, S., Baylies, M. and Skaer, H. (2003). Dual origin of the renal tubules in Drosophila: mesodermal cells integrate and polarize to establish secretory function. Curr. Biol. 13,1052 -1057.[CrossRef][Medline]
Dow, J. A. (2007a). Integrative physiology,
functional genomics and the phenotype gap: a guide for comparative
physiologists. J. Exp. Biol.
210,1632
-1640.
Dow, J. A. (2007b). Model organisms and molecular genetics for endocrinology. Gen. Comp. Endocrinol.153,3 -12.[CrossRef][Medline]
Dow, J. A. and Davies, S. A. (2006). The Malpighian tubule: rapid insights from post-genomic biology. J. Insect Physiol. 52,365 -378.[CrossRef][Medline]
Dow, J. A., Davies, S. A. and Sözen, M. A. (1998). Fluid secretion by the Drosophila Malpighian tubule. Amer. Zool. 38,450 -460.
Dressler, G. R. (2006). The cellular basis of kidney development. Annu. Rev. Cell Dev. Biol. 22,509 -529.[CrossRef][Medline]
Duffield, J. S., Park, K. M., Hsiao, L. L., Kelley, V. R., Scadden, D. T., Ichimura, T. and Bonventre, J. V. (2005). Restoration of tubular epithelial cells during repair of the postischemic kidney occurs independently of bone marrow-derived stem cells. J. Clin. Invest. 115,1743 -1755.[CrossRef][Medline]
Elger, M., Hentschel, H., Litteral, J., Wellner, M., Kirsch, T.,
Luft, F.C. and Haller, H. (2003). Nephrogenesis is induced by
partial nephrectomy in the elasmobranch Leucoraja erinacea. J. Am.
Soc. Nephrol. 14,1506
-1518.
Evans, J. M., Day, J. P., Cabrero, P., Dow, J. A. and Davies, S.
A. (2008). A new role for a classical gene: white transports
cyclic GMP. J. Exp. Biol.
211,890
-899.
Frew, I. J., Thoma, C. R., Georgiev, S., Minola, A., Hitz, M., Montani, M., Moch, H. and Krek, W. (2008). pVHL and PTEN tumour suppressor proteins cooperatively suppress kidney cyst formation. EMBO J. 27,1747 -1757.[CrossRef][Medline]
Gaul, U. and Weigel, D. (1990). Regulation of Kruppel expression in the anlage of the Malpighian tubules in the Drosophila embryo. Mech. Dev. 33, 57-67.[CrossRef][Medline]
Gregory, L., Came, P. J. and Brown, S. (2008). Stem cell regulation by JAK/STAT signaling in Drosophila. Semin. Cell. Dev. Biol. 19,407 -413.[CrossRef][Medline]
Gupta, S. and Rosenberg, M. E. (2008). Do stem cells exist in the adult kidney? Am. J. Nephrol. 28,607 -613.[CrossRef][Medline]
Gupta, S., Verfaillie, C., Chmielewski, D., Kren, S., Eidman,
K., Connaire, J., Heremans, Y., Lund, T., Blackstad, M., Jiang, Y. et al.
(2006). Isolation and characterization of kidney-derived stem
cells. J. Am. Soc. Nephrol.
17,3028
-3040.
Hahn, M. and Bishop, J. (2001). Expression
pattern of Drosophila ret suggests a common ancestral origin between
the metamorphosis precursors in insect endoderm and the vertebrate enteric
neurons. Proc. Natl. Acad. Sci. USA
98,1053
-1058.
Haller, H., Groot, K. D., Bahlmann, F., Elger, M. and Fliser, D. (2005). Stem cells and progenitor cells in renal disease. Kidney Int. 68,1932 -1936.[CrossRef][Medline]
Hatton-Ellis, E., Ainsworth, C., Sushama, Y., Wan, S.,
VijayRaghavan, K. and Skaer, H. (2007). Genetic regulation of
patterned tubular branching in Drosophila. Proc. Natl. Acad. Sci.
USA 104,169
-174.
Henske, E. P. (2005). Tuberous sclerosis and the kidney: from mesenchyme to epithelium, and beyond. Pediatr. Nephrol. 20,854 -857.[CrossRef][Medline]
Hishikawa, K., Marumo, T., Miura, S., Nakanishi, A., Matsuzaki,
Y., Shibata, K., Ichiyanagi, T., Kohike, H., Komori, T., Takahashi, I. et
al. (2005). Musculin/MyoR is expressed in kidney side
population cells and can regulate their function. J. Cell
Biol. 169,921
-928.
Hombría, J. C. and Sotillos, S. (2006). JAK/STAT signalling: STAT cannot play with Ken and Barbie. Curr. Biol. 16,R98 -R100.[CrossRef][Medline]
Hou, S. X. and Singh, S. R. (2008). Germline Stem Cells. Methods in Molecular Biology, vol. 450. Totowa, NJ, USA: Humana Press.
Hou, S. X., Zheng, Z., Chen, X. and Perrimon, N. (2002). The JAK/STAT pathway in model organisms: emerging roles in cell movement. Dev. Cell 3, 765-778.[CrossRef][Medline]
Humphreys, B. D., Valerius, M. T., Kobayashi, A., Mugford, J. W., Soeung, S., Duffield, J. S., McMahon, A. P. and Bonventre, J. V. (2008). Intrinsic epithelial cells repair the kidney after injury. Cell Stem Cell 2, 284-291.[CrossRef][Medline]
Imai, N., Hishikawa, K., Marumo, T., Hirahashi, J., Inowa, T., Matsuzaki, Y., Okano, H., Kitamura, T., Salant, D. and Fujita, T. (2007). Inhibition of histone deacetylase activates side population cells in kidney and partially reverses chronic renal injury. Stem Cells 25,2469 -2475.[CrossRef][Medline]
Imberti, B., Morigi, M., Tomasoni, S., Rota, C., Corna, D.,
Longaretti, L., Rottoli, D., Valsecchi, F., Benigni, A., Wang, J. et al.
(2007). Insulin-like growth factor-1 sustains stem cell mediated
renal repair. J. Am. Soc. Nephrol.
18,2921
-2928.
Ivanov, S. V., Salnikow, K., Ivanova, A. V., Bai, L. and Lerman, M. I. (2007). Hypoxic repression of STAT1 and its downstream genes by a pVHL/HIF-1 target DEC1/STRA13. Oncogene 26,802 -812.[CrossRef][Medline]
Iwatani, H., Ito, T., Imai, E., Matsuzaki, Y., Suzuki, A., Yamato, M., Okabe, M. and Hori, M. (2004). Hematopoietic and nonhematopoietic potentials of Hoechst(low)/side population cells isolated from adult rat kidney. Kidney Int. 65,1604 -1614.[CrossRef][Medline]
Jones, D. L. and Wagers, A. J. (2008). No place like home: anatomy and function of the stem cell niche. Nat. Rev. Mol. Cell. Biol. 9,11 -21.[CrossRef][Medline]
Jung, A., Denholm, B., Skaer, H. and Affolter, M.
(2005). Renal tubule development in Drosophila: a closer look at
the cellular level. J. Am. Soc. Nephrol.
16,322
-328.
Kiger, A. A., Jones, D. L., Schulz, C., Rogers, M. B. and
Fuller, M. T. (2001). Stem cell self-renewal specified by
JAK-STAT activation in response to a support cell cue.
Science 294,2542
-2545.
Kirilly, D., Spana, E. P., Perrimon, N., Padgett, R. W. and Xie, T. (2005). BMP signaling is required for controlling somatic stem cell self-renewal in the Drosophila ovary. Dev. Cell 9,651 -662.[CrossRef][Medline]
Kitamura, S., Yamasaki, Y., Kinomura, M., Sugaya, T., Sugiyama,
H., Maeshima, Y. and Makino, H. (2005). Establishment and
characterization of renal progenitor like cells from S3 segment of nephron in
rat adult kidney. FASEB J.
19,1789
-1797.
Kondo, K., Kim, W. Y., Lechpammer, M. and Kaelin, W. G., Jr (2003). Inhibition of HIF2alpha is sufficient to suppress pVHL-defective tumor growth. PLoS Biol. 1, E83.[Medline]
Kunter, U., Rong, S., Boor, P., Eitner, F., Müller-Newen,
G., Djuric, Z., van Roeyen, C. R., Konieczny, A., Ostendorf, T., Villa, L. et
al. (2007). Mesenchymal stem cells prevent progressive
experimental renal failure but maldifferentiate into glomerular adipocytes.
J. Am. Soc. Nephrol. 18,1754
-1764.
Lee, T. and Luo, L. (2001). Mosaic analysis with a repressible cell marker (MARCM) for Drosophila neural development. Trends Neurosci. 24,251 -254.[CrossRef][Medline]
Li, L. and Xie, T. (2005). Stem cell niche: structure and function. Annu. Rev. Cell. Dev. Biol. 21,605 -631.[CrossRef][Medline]
Lin, F., Moran, A. and Igarashi, P. (2005). Intrarenal cells, not bone marrow-derived cells, are the major source for regeneration in postischemic kidney. J. Clin. Invest. 115,1756 -1764.[CrossRef][Medline]
Lin, H. (2002). The stem-cell niche theory: lessons from flies. Nat. Rev. Genet. 3, 931-940.[CrossRef][Medline]
Liu, S. and Jack, J. (1992). Regulatory interactions and role in cell type specification of the Malpighian tubules by the cut, Kruppel, and caudal genes of Drosophila. Dev. Biol. 150,133 -143.[CrossRef][Medline]
Liu, X., Kiss, I. and Lengyel, J. A. (1999).
Identification of genes controlling Malpighian tubule and other epithelial
morphogenesis in Drosophila melanogaster. Genetics
151,685
-695.
Luo, H. and Dearolf, C. R. (2001). The JAK/STAT pathway and Drosophila development. BioEssays 23,1138 -1147.[CrossRef][Medline]
Maddrell, S. H., Gardiner, B. O., Pilcher, D. E. and Reynolds,
S. E. (1974). Active transport by insect Malpighian tubules
of acidic dyes and of acylamides. J. Exp. Biol.
61,357
-377.
Maeshima, A., Yamashita, S. and Nojima, Y.
(2003). Identification of renal progenitor-like tubular cells
that participate in the regeneration processes of the kidney. J.
Am. Soc. Nephrol. 14,3138
-3146.
Martinez-Agosto, J. A., Mikkola, H. K., Hartenstein, V. and
Banerjee U. (2007). The hematopoietic stem cell and its
niche: a comparative view. Genes Dev.
21,3044
-3060.
Mazzinghi, B., Ronconi, E., Lazzeri, E., Sagrinati, C.,
Ballerini, L., Angelotti, M. L., Parente, E., Mancina, R., Netti, G. S.,
Becherucci, F. et al. (2008). Essential but differential role
for CXCR4 and CXCR7 in the therapeutic homing of human renal progenitor cells.
J. Exp. Med. 205,479
-490.
Micchelli, C. A. and Perrimon, N. (2006). Evidence that stem cells reside in the adult Drosophila midgut epithelium. Nature 439,475 -479.[CrossRef][Medline]
Morrison, S. J. and Spradling, A. C. (2008). Stem cells and niches: mechanisms that promote stem cell maintenance throughout life. Cell 132,598 -611.[CrossRef][Medline]
Nusse, R. (2008). Wnt signaling and stem cell control. Cell Res. 18,523 -527.[CrossRef][Medline]
Nystul, T. and Spradling, A. (2007). An epithelial niche in the Drosophila ovary undergoes long-range stem cell replacement. Cell Stem Cell 1, 277-285.[CrossRef][Medline]
Ohlstein, B. and Spradling, A. (2006). The adult Drosophila posterior midgut is maintained by pluripotent stem cells. Nature 439,470 -474.[CrossRef][Medline]
Ohlstein, B. and Spradling, A. (2007). Multipotent Drosophila intestinal stem cells specify daughter cell fates by differential Notch signaling. Science 1315,988 -992.
Oliver, J. A., Maarouf, O., Cheema, F. H., Martens, T. P. and Al-Awqati, Q. (2004). The renal papilla is a niche for adult kidney stem cells. J. Clin. Invest. 114,795 -804.[CrossRef][Medline]
Park, J. S., Valerius, M. T. and McMahon, A. P.
(2007). Wnt/beta-catenin signaling regulates nephron induction
during mouse kidney development. Development
134,2533
-2539.
Pfaffenroth, E. C. and Linehan, W. M. (2008). Genetic basis for kidney cancer: opportunity for disease-specific approaches to therapy. Expert. Opin. Biol. Ther. 8, 779-790.[CrossRef][Medline]
Rosenblum, N. D. (2008). Developmental biology of the human kidney. Semin. Fetal Neonatal Med. 13,125 -132.[CrossRef][Medline]
Ruiz-Sanchez, E. and O'Donnell, M. J. (2007).
Effects of chronic exposure to dietary salicylate on elimination and renal
excretion of salicylate by Drosophila melanogaster larvae.
J. Exp. Biol. 210,2464
-2471.
Sagrinati, C., Netti, G. S., Mazzinghi, B., Lazzeri, E., Liotta,
F., Frosali, F., Ronconi, E., Meini, C., Gacci, M., Squecco, R. et al.
(2006). Isolation and characterization of multipotent progenitor
cells from the Bowman's capsule of adult human kidneys. J. Am. Soc.
Nephrol. 17,2443
-2456.
Sagrinati, C., Ronconi, E., Lazzeri, E., Lasagni, L. and Romagnani, P. (2008). Stem-cell approaches for kidney repair: choosing the right cells. Trends Mol. Med. 14,277 -285.[CrossRef][Medline]
Saxen, L. (1987). Organogenesis of the kidney. New York: Cambridge University Press.
Schmidt, L. S., Nickerson, M. L., Warren, M. B., Glenn, G. M., Toro, J. R., Merino, M. J., Turner, M. L., Choyke, P. L., Sharma, N., Peterson, J. et al. (2005). Germline BHD-mutation spectrum and phenotype analysis of a large cohort of families with Birt-Hogg-Dubé syndrome. Am. J. Hum. Genet. 76,1023 -1033.[CrossRef][Medline]
Singh, S. R. and Hou, X. S. (2008). Lessons
learned about adult kidney stem cells from the Malpighian tubules of
Drosophila. J. Am. Soc. Nephrol.
19,660
-666.
Singh, S. R., Chen, X. and Hou, S. X. (2005). JAK/STAT signaling regulates tissue outgrowth and male germline stem cell fate in Drosophila. Cell Res. 15, 1-5.[CrossRef][Medline]
Singh, S. R., Zhen, W., Zheng, Z. Y., Wang, H., Oh, S. W., Liu, W., Zbar, B., Schmidt, L. S. and Hou, S. X. (2006). The Drosophila homologue of the human tumor suppressor gene BHD regulates male germline stem cell maintenance and functions downstream of Dpp. Oncogene 25,5933 -5941.[CrossRef][Medline]
Singh, S. R., Liu, W. and Hou X. S. (2007). The adult Drosophila Malpighian tubules are maintained by multipotent stem cell. Cell Stem Cell 1, 191-203.[CrossRef][Medline]
Sneddon, J. B. and Werb, Z. (2007). Location, location, location: the cancer stem cell niche. Cell Stem Cell 1,607 -611.[CrossRef][Medline]
Sözen, M. A., Armstrong, J. D., Yang, M. Y., Kaiser, K. and
Dow, J. A. T. (1997). Functional domains are specified to
single-cell resolution in a Drosophila epithelium. Proc.
Natl. Acad. Sci. USA 94,5207
-5212.
Sudarsan, V., Pasalodos-Sanchez, S., Wan, S., Gampel, A. and Skaer, H. (2002). A genetic hierarchy establishes mitogenic signalling and mitotic competence in the renal tubules of Drosophila.Development 129,935 -944.[Medline]
Takashima, S., Mkrtchyan, M., Younossi-Hartenstein, A., Merriam, J. R. and Hartenstein, V. (2008). The behaviour of Drosophila adult hindgut stem cells is controlled by Wnt and Hh signalling Nature 454,651 -655.[CrossRef][Medline]
Thomas, L. and Kumar, R. (2008). Control of
renal solute excretion by enteric signals and mediators. J. Am.
Soc. Nephrol. 19,207
-212.
Uhlenhaut, N. H. and Treier, M. (2008). Transcriptional regulators in kidney disease: gatekeepers of renal homeostasis. Trends Genet. 24,361 -371.[CrossRef][Medline]
Vaidya, V. S., Ferguson, M. A. and Bonventre, J. V. (2008). Biomarkers of acute kidney injury. Annu. Rev. Pharmacol. Toxicol. 48,463 -493.[CrossRef][Medline]
Vainio, S. and Lin, Y. (2002). Coordinating early kidney development: lessons from gene targeting. Nat. Rev. Genet. 3,533 -543.[CrossRef][Medline]
Vogetseder, A., Picard, N., Gaspert, A., Walch, M., Kaissling,
B. and Le Hir, M. (2008). The proliferation capacity of the
renal proximal tubule involves the bulk of differentiated epithelial cells.
Am. J. Physiol. Cell Physiol.
294,C22
-C28.
Voog, J., D'Alterio, C. and Jones, D. L. (2008). Multipotent somatic stem cells contribute to the stem cell niche in the Drosophila testis. Nature 454,1132 -1136.[CrossRef][Medline]
Wan, S., Cato, A. M. and Skaer, H. (2000). Multiple signalling pathways establish cell fate and cell number in Drosophila Malpighian tubules. Dev. Biol. 217,153 -165.[CrossRef][Medline]
Wang, H., Singh, S. R., Zheng, Z. Y., Oh, S. W., Chen, X., Edwards, K. and Hou, S. X. (2006). A Rap-GEF/Rap GTPase signaling controls stem cell maintenance through regulating adherens junction positioning and cell adhesion in Drosophila testis. Dev. Cell 10,117 -126.[CrossRef][Medline]
Wang, J., Kean, L., Yang, J., Allan, A. K., Davies, S. A., Herzyk, P. and Dow, J. A. (2004). Function-informed transcriptome analysis of Drosophila renal tubule. Genome Biol. 5,R69 .[CrossRef][Medline]
Wessing, A. and Eichelberg, D. (1978). Malpighian tubules, rectal papillae and excretion. In The Genetics and Biology of Drosophila (ed. A. Ashburner and T. R. F. Wright), pp. 1-42. London: Academic Press.
Yamanaka, S. (2007). Strategies and new developments in the generation of patient-specific pluripotent stem cells. Cell Stem Cell 1,39 -49.[CrossRef][Medline]
Yamashita, Y. M. and Fuller, M. T. (2008).
Asymmetric centrosome behavior and the mechanisms of stem cell division.
J. Cell Biol. 180,261
-266.
Yokoo, T., Fukui, A., Matsumoto K. and Okabe, M. (2008). Stem cells and kidney organogenesis. Front. Biosci. 13,2814 -2832.[CrossRef][Medline]
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati
Twitter What's this?
Related articles in JEB:
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||